Quantum Genesis AI Corp. (OTC: QGAI), a technology company focused on artificial intelligence, computational modeling, and scientific innovation, today issued a statement regarding the Caveat Emptor designation placed on the Company’s securities by OTC Markets Group, Inc. on February 12, 2026. The designation, which warns investors to exercise caution, has prompted the Company to seek clarification and initiate a review process.
Since the designation was applied, the Company has made several attempts to communicate with OTC Markets in order to better understand the basis for the designation and to determine what steps may be necessary to address the matter. OTC Markets has indicated that the designation relates to a “public interest concern.” The Company has requested additional clarification and intends to continue cooperating with OTC Markets in order to address the matter. OTC Markets recently informed the Company that it may formally request a review of the Caveat Emptor designation beginning March 13, 2026. Quantum Genesis AI intends to engage with OTC Markets at the earliest available opportunity to initiate that review process.
“We take this matter seriously and are committed to working constructively with OTC Markets to better understand the basis for the designation,” said Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp. “Our objective is to obtain clarity regarding the matter and to take any appropriate steps necessary as we move through the review process.”
The Caveat Emptor designation is a significant regulatory action that can affect a company’s ability to raise capital and may impact investor confidence. By proactively addressing the issue and seeking a review, Quantum Genesis AI aims to mitigate potential negative implications and restore transparency. The Company remains committed to maintaining transparency with its shareholders and the broader investment community. Quantum Genesis AI intends to continue cooperating with OTC Markets and will provide updates as additional information becomes available.
For more information and updates, please visit www.qgaicorp.com and the Company’s profile at www.otcmarkets.com/stock/QGAI.
